Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up

Sanghamitra Mohanty, Carola Gianni, Chintan Trivedi, Tamara Metz, Rong Bai, Amin Al-Ahmad, Shane Bailey, John David Burkhardt, G. Joseph Gallinghouse, Rodney Horton, Patrick M. Hranitzky, Javier E. Sanchez, Luigi Di Biase, Andrea Natale

Research output: Contribution to journalLetter

2 Scopus citations

Abstract

The objective of this study was to evaluate the long-term efficacy of FIRM ablation with PVAI vs PVAI plus posterior wall isolation (PWI) and non-PV trigger ablation in persistent (PeAF) and long-standing persistent AF (LSPAF) patients. The procedure time was recorded to be 180.6 ± 35.9 and 124.03 ± 45.4 minutes in the FIRM+PVI and PVI + PWI + non-PV trigger ablation group respectively. At 24-month follow-up, 24% (95% CI 8.7%–37.8%) in the FIRM-ablation group and 48% (95% CI 27.6–63.3%) in the non-PV trigger ablation group remained arrhythmia-free off-antiarrhythmic drugs after a single procedure. Clinical Trial Registration: ClinicalTrials.gov (Identifier: NCT02533843).

Original languageEnglish (US)
Pages (from-to)145-148
Number of pages4
JournalAmerican Heart Journal
Volume205
DOIs
StatePublished - Nov 1 2018
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Mohanty, S., Gianni, C., Trivedi, C., Metz, T., Bai, R., Al-Ahmad, A., Bailey, S., Burkhardt, J. D., Gallinghouse, G. J., Horton, R., Hranitzky, P. M., Sanchez, J. E., Di Biase, L., & Natale, A. (2018). Impact of rotor ablation in non-paroxysmal AF patients: Findings from the per-protocol population of the OASIS trial at long-term follow-up. American Heart Journal, 205, 145-148. https://doi.org/10.1016/j.ahj.2018.05.021